What is the Jw Pharmaceutical Corporation stock price forecast?

Jw Pharmaceutical Corporation is currently trading at ₩28,050. View real-time AI analysis on Alpha Lenz.

What is Jw Pharmaceutical Corporation insider trading activity?

View the latest insider trading data for Jw Pharmaceutical Corporation on Alpha Lenz.

What is Jw Pharmaceutical Corporation's P/E ratio?

Jw Pharmaceutical Corporation's P/E ratio is 10.2.

Jw Pharmaceutical Corporation

KRX · 001060

₩28,050+1,000(+3.70%)Market closed

Ask about Jw Pharmaceutical Corporation's future dividend policy...

Alpha Chat Insight

“Jw Pharmaceutical Corporation trades at a P/E of 10.2 (undervalued) with strong ROE of 17.6%.”

Ask for details →

Company Overview

Jw Pharmaceutical Corporation is a leading healthcare company engaged in the development, manufacture, and distribution of pharmaceutical products. With a strong focus on innovation and quality, this corporation plays a pivotal role in the pharmaceutical industry by providing a broad array of medicines that address diverse medical needs. The company specializes in pharmaceuticals for cardiovascular, gastrointestinal, and metabolic disorders, including antibiotics and anti-cancer drugs. Additionally, Jw Pharmaceutical is involved in the research and development of advanced pharmaceuticals and biotechnology products, contributing to the expansion of medical solutions on a global scale. This company not only serves the healthcare market with its extensive product line but also collaborates with various international firms to bring cutting-edge medical therapies to different regions. Through its dedication to improving health and well-being, Jw Pharmaceutical Corporation maintains its significance in the pharmaceutical market by continuously adapting to the ever-evolving landscape of healthcare needs.

CEO대표이사 신영섭

Websitehttps://www.jw-pharma.co.kr

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

Employees1,048

Company Statistics

FY 2025

Profile

₩629,884,406,500Market Cap

₩775,298,057,920Revenue

23.29MShares Out

1,048Employees

Margins

46.35%Gross

15.35%EBITDA

12.18%Operating

11.46%Pre-Tax

7.93%Net

Valuation

10.24P/E

1.71P/B

0.81EV/Sales

5.42EV/EBITDA

10.45P/FCF

Growth (CAGR)

4.25%Rev 3Yr

7.21%Rev 5Yr

14.59%Op Inc 3Yr

N/AOp Inc 5Yr

27.25%Net Inc 3Yr

N/ANet Inc 5Yr

Returns

10.17%ROA

17.60%ROE

15.42%ROIC

Financial Health

₩39,232,537,850Cash & Cash Equivalents

₩196,671,029,850Net Debt

63.87%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Jw Pharmaceutical Corporation trades at a P/E of 10.2 (undervalued) with strong ROE of 17.6%.”

Ask for details →

Frequently Asked Questions

Jw Pharmaceutical Corporation (ticker: 001060) is a company listed on KRX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 1,048 employees. Market cap is $629.9B.

The current price is ₩28,050 with a P/E ratio of 10.24x and P/B of 1.71x.

ROE is 17.60% and operating margin is 12.18%. Annual revenue is $775.3B.